Bills · S 1631
IN COMMITTEE· 119TH CONGRESS
Senate BillS 1631Health
Restoring Safeguards for Dangerous Abortion Drugs Act
INTRO MAY 6· LAST ACTION MAY 6
READING
3MIN
COSPONSORS
0
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters to voters because it directly impacts access to medication abortion nationwide. If passed, it would roll back changes made by the FDA over the years that have made mifepristone more accessible, such as allowing it to be prescribed via telehealth and dispensed by pharmacies. This could mean significantly fewer options for individuals seeking to end a pregnancy and a return to more restrictive clinic-based care requirements.
It also matters because it introduces new legal liabilities for healthcare providers and pharmacies regarding mifepristone, potentially creating a chilling effect on the willingness of some providers to offer the medication. The ban on importation could further limit the supply and availability of the drug. If this bill doesn't become law, the current, less restrictive FDA regulations for mifepristone would remain in place, allowing for broader access through telehealth and pharmacies, and providers would not face the specific new federal tort liability outlined in the bill.
KEY PROVISIONS
3AI-extractedPROVISION 01
Requires the Secretary of Health and Human Services to replace the current safety rules (Risk Evaluation and Mitigation Strategy or REMS) for mifepristone with the stricter rules that were in place in June 2011.
This provision would significantly restrict how mifepristone can be prescribed and dispensed, potentially requiring in-person doctor visits and limiting pharmacy dispensing.
PROVISION 02
Creates a new federal civil lawsuit for individuals who suffer harm from mifepristone that was knowingly imported or transported illegally by certain entities (like telehealth providers or pharmacies).
This provision establishes a new legal pathway for individuals to seek damages and creates significant legal risk for healthcare entities involved in providing mifepristone under certain conditions.
PROVISION 03
Bans the importation of mifepristone into the United States by any person, including by mailing the drug to individuals.
This provision aims to prevent alternative pathways for obtaining mifepristone, further limiting its availability and control within the U.S. regulatory system.
SPONSORSHIP
1 + 0
R· Missouri
YRS IN OFFICE
7
BILLS LED
51
ACTION TIMELINE
2 EVENTSMAY 6
Introduced in Senate
MAY 6
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 1631
Congress119th
StatusIn Committee
IntroducedMay 6, 2025
Last actionMay 6, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED MAY 6, 2025
Senate BillS 1631Health
Restoring Safeguards for Dangerous Abortion Drugs Act
INTRODUCED MAY 6, 2025· LAST ACTION MAY 6, 2025
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
0
COMPLEXITY
Moderate
